Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 – Full Text View – ClinicalTrials.gov

Post author By Pete's Library
Post date January 30, 2023
No Comments on Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 – Full Text View – ClinicalTrials.gov

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 (ACHIEVE)
— Read on clinicaltrials.gov/ct2/show/NCT05481879

Share this:

Leave a comment Cancel reply